Moffitt Cancer Center and Cryoport Announce Strategic Collaboration
Cryoport's CRYOGENE will provide Moffitt with state-of-the-art biorepository services TAMPA, Fla. and NASHVILLE, Tenn., Jan. 14, 2025 /PRNewswire/ -- Moffitt Cancer...
Financial
RespondHealth collaborates with Microsoft to advance AI-Powered Real-World Health Intelligence
BETHESDA, Md., Jan. 13, 2025 /PRNewswire/ -- RespondHealth, a real-world evidence (RWE) clinical discovery company, is pleased to announce a new...
Switchboard, MD Announces ThreatAware: AI-Powered Support for Clinicians Addressing Emerging Health Threats
ATLANTA, Jan. 13, 2025 /PRNewswire/ -- Switchboard, MD is announcing the launch of ThreatAware, an advanced solution designed to identify...
Vevo Therapeutics to Open Source Milestone Tahoe-100M Dataset
Tahoe-100M is the world's largest single-cell atlas of how drug molecules impact biology of patient cells SOUTH SAN FRANCISCO, Calif.,...
Kognitic’s AI Model Revolutionizes Primary Completion Date Predictions for Clinical Trials
A newly published study shows Kognitic's AI reduces clinical trial primary completion date prediction errors from 508 to 179 days,...
The New York Stem Cell Foundation Research Institute Enters Agreement to Accelerate Precision Drug Discovery for Neurodegenerative Disease
Partnership Will Harness NYSCF's Automated Cell Culture Systems and Artificial Intelligence Capabilities to Study Disease at an Unprecedented Cellular Level NEW...
Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in Oncology
This is the second asset Menarini Group has inlicensed from Insilico Medicine which was discovered through their generative AI platform,...
Totus Medicines Announces Successful Completion of a Phase 1 Dose-Escalation Study and Initiation of an Expansion Trial Evaluating TOS-358, a Covalent PI3Ka Selective Therapy for the Treatment of Select Solid Tumors and Appoints Zelanna Goldberg as Chief Medical Officer
Successfully completed a Phase 1 dose-escalation study demonstrating pan-mutant clinical activity, 95% target engagement and no grade 3 or 4...
Generate:Biomedicines Provides Update on its Platform and Pipeline Powered by AI at the 43rd Annual J.P. Morgan Healthcare Conference
SOMERVILLE, Mass., Jan. 9, 2025 /PRNewswire/ -- Generate:Biomedicines ("Generate") today announced that Mike Nally, Chief Executive Officer, will provide an...
AI/ML Innovations Inc. Welcomes Industry Veterans to Board of Directors
Mark Orsmond, a highly respected business professional in Canadian Healthcare, Appointed Executive ChairMichael Nemirow Joins as Director, Bringing Decades of...
Frontier Medicines Announces FMC-220, the First Covalent p53 Y220C Activator Development Candidate, with Best-in-Class Potential
FMC-220 is a first-in-class covalent activator of p53Y220C designed to address potency and tolerability challenges of non-covalent approachesIn preclinical studies,...
Frontier Medicines to Present at the 43rd Annual J.P. Morgan Healthcare Conference
BOSTON and SOUTH SAN FRANCISCO, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation (“Frontier” or the “Company”), a...
From Generative AI and ML to Quantum Computing, Bio-IT World 2025 Showcases Technologies Poised to Accelerate Lifesaving Therapies
Premier International Conference & Expo To Bring Together 3,000 Life Sciences and IT Leaders Focused on Advancing Precision Medicine BOSTON,...
ScreenPoint Medical Acquires Biomediq A/S to Expand Breast Cancer Risk Assessment Capabilities
Research Published in Radiology Shows that Combination of Transpara-based Lesion Detection, Volumetric Density and Quantitative Texture Analysis Delivers Improved Breast...
TriageLogic Launches TriageIntelligence(TM) and Releases Updated Nurse Triage Handbook
JACKSONVILLE, FLORIDA / ACCESSWIRE / January 8, 2025 / TriageLogic, a leader in telehealth triage solutions, has announced two major...
Unnatural Products Appoints Abbas Kazimi and Mert Aktar to Board of Directors
SANTA CRUZ, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Unnatural Products, Inc. (UNP), a biotech developing orally-delivered macrocyclic peptides to...
Clarivate Identifies Eleven Potential Blockbuster and Transformative Drugs in Annual Drugs to Watch Report
Anticipated advancements in obesity, oncology, gene therapy and other areas poised to revolutionize patient care LONDON, Jan. 8, 2025 /PRNewswire/...
Alternative Credentials Market for Higher Education to Grow by USD 1.84 Billion (2025-2029), Driven by Skills Gap and AI Redefining the Market Landscape – Technavio
NEW YORK, Jan. 7, 2025 /PRNewswire/ -- Report with market evolution powered by AI - The global alternative credentials market...
WCG Unveils 2025 Trends and Insights Report: Driving Innovation and Excellence in Clinical Research
PRINCETON, N.J., Jan. 7, 2025 /PRNewswire/ -- WCG, a global leader in providing solutions that measurably improve and accelerate clinical...
Caris Life Sciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference
IRVING, Texas, Jan. 7, 2025 /PRNewswire/ -- Caris Life Sciences® (Caris), a leading next-generation AI TechBio company and precision medicine...